Q
QuVa Pharma
A pharmaceutical company engaged in the innovation and production of pharmaceutical products
About QuVa Pharma
QuVa Pharma operates in the 503B compounding market, providing high-quality, ready-to-administer pharmaceutical products to hospitals and healthcare facilities. The company focuses on delivering transparent and proactive customer service, process improvement consulting, and new product development through its innovation engine. QuVa Pharma serves healthcare providers who require reliable and compliant pharmaceutical solutions to meet clinical and patient care needs. The business model revolves around manufacturing and supplying compounded sterile preparations, ensuring regulatory compliance, and maintaining high standards of quality. Revenue is generated through the sale of these compounded products and consulting services. QuVa Pharma positions itself as a partner to healthcare providers, helping them stay ahead in an evolving regulatory environment.
Source: Dealroom company dataAt a glance
- Founded
- 2015
- Headquarters
- Sugar Land, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series B and later7 investors entered at this stage
Bain Capital
Farnam Street Financial
Standard Treasury
Silicon Valley Bank
Oxford Finance
Goldman Sachs
Blue Owl Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about QuVa Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See QuVa Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.